Short Stature

Common Name(s)

Short Stature

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Short Stature" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Short Stature" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Short Stature" returned 338 free, full-text research articles on human participants. First 3 results:

Short stature and hypothyroidism in a child with Nail-Patella Syndrome. A case report.
 

Author(s): C Goecke, C Mellado, C García, H García

Journal: Rev Chil Pediatr. 2018 Feb;89(1):107-112.

 

Nail-Patella syndrome (NPS) (OMIM: 161200) or hereditary onycho-osteodysplasia is an autosomal dominant disorder characterized by skeletal anomalies, nail dysplasia, renal and ocular abnor malities. The diagnosis is based on clinical and radiological findings and confirmed by the ...

Last Updated: 31 Dec 1969

Go To URL
A Case With Short Stature, Growth Hormone Deficiency and 46, XX, Xq27-qter Deletion.
 

Author(s): Şule Yıldırım, Naci Topaloğlu, Mustafa Tekin, Fatma Sılan

Journal: Acta Med Iran. 2017 Oct;55(10):661-663.

 

We report a case of 11-year-old girl with growth retardation and 46, XX, Xq27-qter deletion. The endocrinologic evaluation revealed growth hormone deficiency. In karyotype analysis  46, XX, Xq27-qter deletion was determined. The deletion of terminal region of chromosome 27 is most ...

Last Updated: 31 Dec 1969

Go To URL
Spectrum of Disproportionate Short Stature at a Tertiary-care Center in Northern India.
 

Author(s): Ankur Singh, Gaurav Pradhan, Rajniti Prasad, Om Prakash Mishra, Seema Kapoor

Journal: Indian Pediatr. 2017 Nov;54(11):971-972.

 

Forty cases with disproportionate short stature (median age 3.1 y; 24 males) from genetic clinic of Lok Nayak Hospital, Delhi were assessed in this study. Achondroplasia was the commonest (n=9) skeletal dysplasia; conclusive diagnosis was not possible in six children. Molecular confirmation ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Short Stature" returned 44 free, full-text review articles on human participants. First 3 results:

The Rationale for Growth Hormone Therapy in Children with Short Stature.
 

Author(s): Annalisa Deodati, Stefano Cianfarani

Journal: J Clin Res Pediatr Endocrinol. 2017 Dec;9(Suppl 2):23-32.

 

Growth hormone (GH) was first isolated from cadaver pituitary glands, requiring laborious and expensive collection of glands, followed by extraction and purification of the hormone. This limited supply restricted its use to children with severe GH deficiency who were treated with ...

Last Updated: 31 Dec 1969

Go To URL
The use of aromatase inhibitors in boys with short stature: what to know before prescribing?
 

Author(s): Alessandra Linardi, Durval Damiani, Carlos A Longui

Journal: Arch Endocrinol Metab. ;61(4):391-397.

 

Aromatase is a cytochrome P450 enzyme (CYP19A1 isoform) able to catalyze the conversion of androgens to estrogens. The aromatase gene mutations highlighted the action of estrogen as one of the main regulators of bone maturation and closure of bone plate. The use of aromatase inhibitors ...

Last Updated: 31 Dec 1969

Go To URL
Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence.
 

Author(s): Adda Grimberg, David B Allen

Journal: Curr. Opin. Pediatr.. 2017 Aug;29(4):466-471.

 

The Pediatric Endocrine Society recently published new guidelines for the use of human growth hormone (hGH) and human insulin-like growth factor-I (hIGF-I) treatment for growth hormone deficiency, idiopathic short stature, and primary IGF-I deficiency in children and adolescents. ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 17 Jul 2017

Go to URL